Demand Planning in Life Sciences During COVID-19

The COVID-19 pandemic has revealed the vulnerability of pharmaceutical supply chains. Pharma companies are focusing on risk management to improve the resilience of their networks. Most of the measures they will take, including on-shoring, over capacities and redundancies, will lead to higher costs. To decrease inventory levels across these new …